А. В. Хрипун

ORCID: 0000-0001-6765-2837
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Healthcare Systems and Public Health
  • Atrial Fibrillation Management and Outcomes
  • Neurological Disorders and Treatments
  • Cerebrovascular and Carotid Artery Diseases
  • Coronary Interventions and Diagnostics
  • Cardiac Arrhythmias and Treatments
  • Cardiovascular Function and Risk Factors
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac electrophysiology and arrhythmias
  • Peripheral Artery Disease Management
  • Cardiovascular Health and Disease Prevention
  • Cardiac, Anesthesia and Surgical Outcomes
  • Hormonal and reproductive studies
  • Blood Pressure and Hypertension Studies
  • Cardiac Health and Mental Health
  • Lipoproteins and Cardiovascular Health
  • Cardiovascular Disease and Adiposity
  • Sodium Intake and Health
  • Acute Ischemic Stroke Management
  • Respiratory Support and Mechanisms
  • Lipid metabolism and disorders
  • Chronic Kidney Disease and Diabetes
  • Nuclear Structure and Function

Rostov State Medical University
2013-2024

Rostov Research Institute of Oncology
2013-2018

Objective : to assess the incidence of newly diagnosed subclinical and manifest hypothyroidism in patients with ST-segment elevation myocardial infarction (STEMI) identify angiographic features coronary artery lesions this combined pathology. Materials methods all STEMI, level thyroid-stimulating hormone (TSH) was determined, thyroid function assessed if TSH deviated from norm. Stage I study included 441 patients, stage II 133 STEMI. Depending on presence hypothyroidism, were divided into 3...

10.21886/2219-8075-2024-15-3-55-61 article EN cc-by Medical Herald of the South of Russia 2024-09-27

Objective : to evaluate the features of structural and functional remodeling left heart during hospitalization in patients with ST-segment elevation myocardial infarction (STEMI) concomitant newly diagnosed hypothyroidism. Materials methods: study included 133 STEMI aged 40 88 years admitted Rostov Regional Clinical Hospital. All were divided into 3 groups depending on hypothyroidism: Group 1 (control) without hypothyroidism syndrome (n=57), 2A — subclinical (n=42) 2B manifest (n=34)....

10.21886/2712-8156-2024-5-3-36-45 article EN South Russian Journal of Therapeutic Practice 2024-09-27

Aim. To evaluate efficacy of pharmacoinvasive strategy (PCS) treatment in ST elevation myocardial infarction (STEMI) Rostovskaya Region, during the nearest (in-patient) period. Material and methods. The analysis performed, 587 STEMI patients, who were referred to Regional Vascular Center “ROKB” Rostov-na-Donu city from hospitals neighborhoods since January 2010 till June 2015, with aim undergo percutaneous coronary intervention (PCI) after thrombolytic therapy (TT) as PCS reperfusion...

10.15829/1560-4071-2016-3-101-106 article EN cc-by Russian Journal of Cardiology 2016-03-30

In the conclusion of council experts (list participants see text) following issues are discussed: regional specifics diagnostics and therapy patients with ischemic heart disease (IHD) / or peripheral arterial (PAD), methods risk assessment in stable course atherosclerotic disease, pathogenetic validity simultaneous inhibition coagulation platelet thrombus formation, as well clinical significance a novel therapeutic approach – combined use rivaroxaban acetylsalicylic acid (ASA). Possible...

10.18087/cardio.2019.9.n671 article EN cc-by Kardiologiia 2019-09-21

THE AIM. Assessment of the impact renal dysfunction and imbalance body aquatic environments distribution on risk developing cardiovascular complications in late period after acute coronary syndrome (ACS) myocardial revascularization. PATIENTS AND METHODS. We examined 120 patients with ACS undergoing estimated traditonal factors (albuminuria 30-300 mg/l, value GFR, kidney injury development), factors. Upon completion primary material processing, to determine effect studied factors, we...

10.24884/1561-6274-2017-21-1-39-45 article EN cc-by-nc-nd Nephrology (Saint-Petersburg) 2017-03-03

The conclusion of the Expert Council reports an agreement on place P2Y 12 receptor blocker prasugrel in early invasive treatment patients with acute coronary syndrome ACS, according to results multicenter randomized controlled study ISAR-REACT 5. Prasugrel should be considered preferred planned primary percutaneous intervention and management ST segment elevation ACS. Herewith, intake non-ST ACS is preferable after angiography decision for stenting.

10.15829/1560-4071-2019-11-92-97 article EN cc-by Russian Journal of Cardiology 2019-11-26

Abstract Background To date, knowledge about the effects of testosterone (T) on cardiovascular system men remains controversial and requires additional research. Especially putative impact T replacement therapy (TRT) lipid metabolism endothelial dysfunction as a starting mechanism for development pathology in with type 2 diabetes mellitus (T2DM) presenting deficiency has to be elucidated. The aim this work was evaluate effect function endothelium T2DM hypogonadism. Methods study included 95...

10.1093/ehjci/ehaa946.3827 article EN European Heart Journal 2020-11-01

Purpose: ST-elevation myocardial infarction due to the left main coronary artery disease is one of most life-threatening conditions in daily clinical practice. Methods: Of 1127 PCIs performed STEMI patients at our hospital from January 1, 2009 December 31, 2011, stem was culprit lesion 43 (3.8%) cases. A retrospective analysis treatment (mean age 64.7±6.5 years, 74.4% were males) presenting with that underwent PCI a single high-volume center performed. The study end points included...

10.1093/eurheartj/eht308.p1276 article EN European Heart Journal 2013-08-02

Despite the advances in lipidology over past decade, control of dyslipidemia at population level Russia, as a number European countries, remains unsatisfactory. The need for novel organizational approaches to solving problem regional and federal levels is obvious. This publication provides an overview implemented projects successful practical experience lipid centers well prospects development models that will optimize care provision patients with metabolism disorders level.

10.15829/1560-4071-2021-4538 article EN cc-by Russian Journal of Cardiology 2021-07-16

There is limited information on the comparative results of using different thrombolytic drugs for pharmacoinvasive reperfusion in acute ST-segment elevation myocardial infarction (STEMI). special interest comparing efficacy fibrin-selective and fibrin-non-selective thrombolytics. Aim. To study prevalence major adverse cardiovascular events status patients who had STEMI a year ago, depending choice drug. Material methods . 240 STEMI-patients undergoing (reference event) were divided into 4...

10.20996/1819-6446-2019-15-2-180-190 article EN cc-by Rational Pharmacotherapy in Cardiology 2019-05-06

The review presents an analysis of experimental and clinical studies on the neuroprotective properties erythropoietin. suggestion about possible participation deficiency erythropoietin in development cerebral disorders patients with chronic renal failure. possibility use drugs recombinant to protect brain, main currently known mechanisms for implementation its potential, not connected influence erythropoiesis. Stressed need early преддиализного monitoring functions сentral nervous system...

10.21886/2219-8075-2014-3-28-35 article EN DOAJ (DOAJ: Directory of Open Access Journals) 2014-09-01

Pheochromocytoma (PC) is a tumor of chromaffin cells the sympathetic-adrenal system that produces large amount catecholamines (adrenaline, norepinephrine, dopamine). There are no reliable data in literature on frequency cardiac manifestations pheochromocytoma, which associated with rarity this pathology. This case demonstrates development catecholamine-induced cardiomyopathy, proceeding under guise heart attack, as primary manifestation pheochromocytoma. The patient was referred diagnosis...

10.21886/2712-8156-2023-4-2-115-121 article EN cc-by South Russian Journal of Therapeutic Practice 2023-06-06

Werner's syndrome is a disease characterized by premature aging, including the earlier development of diseases cardiovascular system: generalized atherosclerosis, hypertension, ischemic heart disease, and occurrence fatal complications such as myocardial infarction, stroke, at younger age. It are main cause death patients with Werner syndrome, whose life expectancy does not exceed 50 years. Therefore, this need regular monitoring for early detection signs diseases, an increase in quality...

10.21886/2712-8156-2023-4-3-108-113 article EN cc-by South Russian Journal of Therapeutic Practice 2023-09-23
Coming Soon ...